The pharmaceutical world is seeing a major shift in glucose therapy with the introduction of GLP-1 transdermal devices. These systems offer a potentially more user-friendly alternative to shots of GLP-1 drugs, minimizing the frequency of daily needle pricks. The technology releases the drug direc